publication date: Mar. 27, 2015

Petition Supporting MD Anderson Administration Gets Signatures of 17 Percent of Center’s Faculty

 

About 17 percent of the faculty members at MD Anderson Cancer Center signed a petition that disagreed with the institution’s Faculty Senate in its efforts to step in and improve morale at the Houston-based institution.

The Faculty Senate recently sent out a letter requesting that the UT System officials and the Board of Regents “provide guidance” to the MD Anderson administration “in establishing milestones and timelines to implement measures to improve the morale of the faculty and the general health of the Institution” (The Cancer Letter, Feb. 20).

Responding to this appeal for help from Austin, three former chairs of the Faculty Senate who now hold administrative positions launched a petition stating that the position taken by the Executive Committee of the Faculty Senate “cannot be said to reflect the full feelings of the faculty at large, and was not in the best interest of this institution, the faculty, the staff, the Faculty Senate, and most importantly the people who entrust us with their lives today and those whom our research will help in the future.”

In a letter that accompanied the petition, the three former Faculty Senate chairs wrote:

“It was conveyed to us that a number of senators believe that the Executive Committee of the Faculty Senate (ECFS) actions did not accurately reflect what they understood to have occurred in November 2014. We also heard from many faculty members at large who believe it does not fully represent their true sentiments nor is it a comprehensive depiction of the current environment.”

Continue reading 41-12 Petition Supporting MD Anderson Administration Gets Signatures Of 17 Percent of Center’s Faculty
To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.